Rep. JoAnn D. Osmond

Filed: 2/27/2014

 

 


 

 


 
09800HB3645ham001LRB098 12715 RPS 56061 a

1
AMENDMENT TO HOUSE BILL 3645

2    AMENDMENT NO. ______. Amend House Bill 3645 as follows:
 
3on page 8, immediately below line 26, by inserting the
4following:
 
5    "Section 12. The Nursing Home Care Act is amended by
6changing Section 2-104 as follows:
 
7    "(210 ILCS 45/2-104)  (from Ch. 111 1/2, par. 4152-104)
8    Sec. 2-104. (a) A resident shall be permitted to retain the
9services of his own personal physician at his own expense or
10under an individual or group plan of health insurance, or under
11any public or private assistance program providing such
12coverage. However, the facility is not liable for the
13negligence of any such personal physician. If a resident
14retains the services of a naturopathic physician as his
15personal physician, the resident's care must be overseen by a

 

 

09800HB3645ham001- 2 -LRB098 12715 RPS 56061 a

1physician licensed to practice medicine in all of its branches
2in accordance with a written agreement between the physicians.
3The Department shall adopt rules setting forth the minimum
4requirements for such an agreement. Every resident shall be
5permitted to obtain from his own physician or the physician
6attached to the facility complete and current information
7concerning his medical diagnosis, treatment and prognosis in
8terms and language the resident can reasonably be expected to
9understand. Every resident shall be permitted to participate in
10the planning of his total care and medical treatment to the
11extent that his condition permits. No resident shall be
12subjected to experimental research or treatment without first
13obtaining his informed, written consent. The conduct of any
14experimental research or treatment shall be authorized and
15monitored by an institutional review board appointed by the
16Director. The membership, operating procedures and review
17criteria for the institutional review board shall be prescribed
18under rules and regulations of the Department and shall comply
19with the requirements for institutional review boards
20established by the federal Food and Drug Administration. No
21person who has received compensation in the prior 3 years from
22an entity that manufactures, distributes, or sells
23pharmaceuticals, biologics, or medical devices may serve on the
24institutional review board.
25    The institutional review board may approve only research or
26treatment that meets the standards of the federal Food and Drug

 

 

09800HB3645ham001- 3 -LRB098 12715 RPS 56061 a

1Administration with respect to (i) the protection of human
2subjects and (ii) financial disclosure by clinical
3investigators. The Office of State Long Term Care Ombudsman and
4the State Protection and Advocacy organization shall be given
5an opportunity to comment on any request for approval before
6the board makes a decision. Those entities shall not be
7provided information that would allow a potential human subject
8to be individually identified, unless the board asks the
9Ombudsman for help in securing information from or about the
10resident. The board shall require frequent reporting of the
11progress of the approved research or treatment and its impact
12on residents, including immediate reporting of any adverse
13impact to the resident, the resident's representative, the
14Office of the State Long Term Care Ombudsman, and the State
15Protection and Advocacy organization. The board may not approve
16any retrospective study of the records of any resident about
17the safety or efficacy of any care or treatment if the resident
18was under the care of the proposed researcher or a business
19associate when the care or treatment was given, unless the
20study is under the control of a researcher without any business
21relationship to any person or entity who could benefit from the
22findings of the study.
23    No facility shall permit experimental research or
24treatment to be conducted on a resident, or give access to any
25person or person's records for a retrospective study about the
26safety or efficacy of any care or treatment, without the prior

 

 

09800HB3645ham001- 4 -LRB098 12715 RPS 56061 a

1written approval of the institutional review board. No nursing
2home administrator, or person licensed by the State to provide
3medical care or treatment to any person, may assist or
4participate in any experimental research on or treatment of a
5resident, including a retrospective study, that does not have
6the prior written approval of the board. Such conduct shall be
7grounds for professional discipline by the Department of
8Financial and Professional Regulation.
9    The institutional review board may exempt from ongoing
10review research or treatment initiated on a resident before the
11individual's admission to a facility and for which the board
12determines there is adequate ongoing oversight by another
13institutional review board. Nothing in this Section shall
14prevent a facility, any facility employee, or any other person
15from assisting or participating in any experimental research on
16or treatment of a resident, if the research or treatment began
17before the person's admission to a facility, until the board
18has reviewed the research or treatment and decided to grant or
19deny approval or to exempt the research or treatment from
20ongoing review.
21    (b) All medical treatment and procedures shall be
22administered as ordered by a physician. All new physician
23orders shall be reviewed by the facility's director of nursing
24or charge nurse designee within 24 hours after such orders have
25been issued to assure facility compliance with such orders.
26    All physician's orders and plans of treatment shall have

 

 

09800HB3645ham001- 5 -LRB098 12715 RPS 56061 a

1the authentication of the physician. For the purposes of this
2subsection (b), "authentication" means an original written
3signature or an electronic signature system that allows for the
4verification of a signer's credentials. A stamp signature, with
5or without initials, is not sufficient.
6    According to rules adopted by the Department, every woman
7resident of child-bearing age shall receive routine
8obstetrical and gynecological evaluations as well as necessary
9prenatal care.
10    (c) Every resident shall be permitted to refuse medical
11treatment and to know the consequences of such action, unless
12such refusal would be harmful to the health and safety of
13others and such harm is documented by a physician in the
14resident's clinical record. The resident's refusal shall free
15the facility from the obligation to provide the treatment.
16    (d) Every resident, resident's guardian, or parent if the
17resident is a minor shall be permitted to inspect and copy all
18his clinical and other records concerning his care and
19maintenance kept by the facility or by his physician. The
20facility may charge a reasonable fee for duplication of a
21record.
22(Source: P.A. 96-1372, eff. 7-29-10; 97-179, eff. 1-1-12.)".